… entered clinical development and a few have been licensed and commercialized. This article
reviews VLP-based vaccines … in animal models and their status in clinical development. …

… and compare the vaccine platforms, and summarize the results of early clinical trials. To date,
… neoantigen vaccines in early stage clinical trials. A total of ?10? phase 1 clinical trials are …

… target for a vaccine, the next steps involve choosing the vaccine platform, adjuvant, … a vaccine
before it reaches the clinic. Given the example of COVID-19 vaccine development, vaccine …

… vaccine platforms. This analysis shows that, overall, vaccines and vaccine candidates using
vaccine platforms … -19 pandemic have advanced in clinical development. This is reasonable, …

… for use as stand-alone vaccines or as vaccine platforms. This review discusses the
development of VLP-based platform technologies for vaccines against pathogens, as well as …

… a clinical development program is placed on vaccine efficacy. For candidate vaccines, the
most common model used to evaluate vaccine efficacy … Although RWD platform cannot capture …

… -effective vaccines and vaccine platform for broad application in the developing world is
highly significant. Finally, new concept of vaccine delivery, such edible vaccines produced by …

… pre-clinical studies [17]. At present, three of the … vaccines are currently in phase III clinical
trials (Table 1). Compared to other vaccine platforms, the mRNA-based SARS-CoV-2 vaccine is …

… vaccine platform using an array of viral products. The studies examine the efficiency of loading
an HIV-1 Nef mut -based vaccine platform … at increasing the vaccine platform safety profile …

… Vaccine platforms have been critical for accelerating the timeline of COVID-19 vaccine
development… The COVID-19 pandemic has demonstrated the importance of vaccine platforms that …